newsfilter
← Latest News
GlobeNewswire·

ObsEva Evidences Compliance with Nasdaq's Stockholder's Equity Rule and Announces Moratorium Dismissal Request Filing

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 14, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN)), a biopharmaceutical company developing and commercializing novel